Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement : Thomas Köhler, Elke Schwier, Dietrich Henzler, Claas Eickmeyer ; Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr University Bochum, Klinikum Herford, Herford, Germany

Míreanna comhchosúla

• High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
  de réir: Schultz, Philipp, et al.
  Foilsithe / Cruthaithe: (2021)
• Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
  de réir: Hawchar, Fatime, et al.
  Foilsithe / Cruthaithe: (2022)
• Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
  de réir: Köhler, Thomas, et al.
  Foilsithe / Cruthaithe: (2022)
• Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
  de réir: Köhler, Thomas, et al.
  Foilsithe / Cruthaithe: (2021)
• The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
  de réir: Unterberg, Matthias, et al.
  Foilsithe / Cruthaithe: (2022)